Effects of pioglitazone and rosiglitazone on aortic vascular function in rat genetic hypertension

被引:12
|
作者
Llorens, Silvia
Mendizabal, Yolanda
Nava, Eduardo [1 ]
机构
[1] Univ Castilla La Mancha, Sch Med, Dept Med Sci, Albacete 02006, Spain
[2] Reg Ctr Biomed Res CRIB, Albacete 02006, Spain
关键词
glitazones; endothelium; hypertension;
D O I
10.1016/j.ejphar.2007.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glitazones have beneficial antihypertensive effects independent of their insulin-sensitizing action. We have studied the effects of pioglitazone and rosiglitazone on the endothelial ability to counteract vascular smooth muscle contractility in genetic hypertension. To achieve this, we measured isometric responses of aortic segments obtained from spontaneously hypertensive rats. The effects of glitazones on endothelial function were studied by assessing the endothelial modulation of phenylephrine-induced isometric contractions (10(-9)- 10(-5) M) in the presence or absence of pioglitazone or rosiglitazone (10(-5) M), added directly to an organ bath or orally administered to the rats (pioglitazone, 10 mg/kg). The role of both NO and prostanoids was analyzed by performing experiments in the presence of N-G-nitro-L-arginine methyl ester (L-NAME) and/or indomethacin (both 10(-5) M) in the organ bath. Concentration-dependent contractions to L-NAME (10(-6)-3 x 10(-4) M) in the presence or absence of glitazones were carried out as an estimation of basal NO release. Pioglitazone, but not rosiglitazone, increased contractile responses to phenylephrine in intact vessels. The contractile responses to phenylephrine obtained in the presence of glitazones were markedly diminished by indomethacin, but enhanced by L-NAME. Analogous results were obtained in aortas from pioglitazone-chronically treated animals. L-NAME concentration-dependent contractions were enhanced by both glitazones. Both glitazones lowered the sensitivity to acetylcholine (10(-9)-10(-5) M). In conclusion, pioglitazone and rosightazone alter vascular function differentially and through endothelium-dependent mechanisms. These drugs act over the same pathways on the endotheliurn where they have a dual action, increasing both production of vasoconstrictor prostanoids and NO. The balance between both vasoactive substances determines the vascular response to glitazones. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 50 条
  • [1] Effects of Pioglitazone and Rosiglitazone on Vascular Function of Mesenteric Resistance Arteries in Rat Genetic Hypertension
    Mendizabal, Yolanda
    Llorens, Silvia
    Nava, Eduardo
    [J]. PHARMACOLOGY, 2011, 88 (1-2) : 72 - 81
  • [2] VASCULAR EFFECTS OF CAPTOPRIL IN THE PREVENTION OF GENETIC-HYPERTENSION IN THE RAT
    FRESLON, JL
    GIUDICELLI, JF
    [J]. JOURNAL DE PHARMACOLOGIE, 1982, 13 (01) : 134 - 135
  • [3] Effects of diet on vascular and endothelial function in rat aortic rings
    ORourke, M
    Docherty, JR
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1996, 493P : S81 - S82
  • [4] Effects of chronic quercetin treatment on blood pressure, vascular function and aortic superoxide anion production in genetic hypertension
    Sanchez, M.
    Galisteo, M.
    Vera, R.
    Villar, I. C.
    Garcia-Saura, M. F.
    Perez-Vizcaino, F.
    Zarzuelo, A.
    Duarte, J.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 64 - 64
  • [5] PIOGLITAZONE IMPROVES CEREBRAL VASCULAR FUNCTION IN OBESE AND LEAN ZUCKER RAT
    Martinez Gomez, A. C.
    Hernandez Rodriguez, M.
    Garcia Sacristan, A.
    Prieto Ocejo, D.
    Benedito Castellote, S.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 28 - 28
  • [6] Rosiglitazone and Pioglitazone Have Opposite Effects on Skeletal Muscle Mitochondrial Content and Function in Type 2 Diabetes
    Rabol, Rasmus
    Boushel, Robert
    Almdal, Thomas
    Ploug, Thorkil
    Haugaard, Steen B.
    Madsbad, Sten
    Dela, Flemming
    [J]. DIABETES, 2009, 58 : A67 - A67
  • [7] Effects of diltiazem on aortic function in arterial hypertension
    Dernellis, JM
    Stefanadis, CI
    Vlachopoulos, C
    Tsioufis, C
    Tsiamis, L
    Toutouzas, CP
    Pitsavos, C
    Toutouzas, PC
    [J]. CIRCULATION, 1997, 96 (08) : 113 - 113
  • [8] Dyslipidaemia in Type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone
    Mukhtar, R
    Reckless, JPD
    [J]. DIABETIC MEDICINE, 2005, 22 : 6 - 10
  • [9] Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation
    Hirakata, M
    Tozawa, R
    Imura, Y
    Sugiyama, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 323 (03) : 782 - 788
  • [10] A comparison of the effects of pioglitazone versus rosiglitazone on edema and weight gain
    Jacober, SJ
    Kendall, DM
    Buse, JB
    Goldberg, RB
    Deeg, MA
    Zagar, AJ
    Khan, MA
    Perez, AT
    Tan, MH
    [J]. DIABETOLOGIA, 2005, 48 : A281 - A281